Exploring the Complexity of COVID-19 Diagnostic Tests

Clinical diagnoses and epidemiological surveillance of the COVID-19 pandemic relies on the availability of highly sensitive, scalable, and low-cost tests. Given the urgent and massive demand for testing in the United States, the Food and Drug Administration (FDA) has been issuing Emergency Use Authorizations (EUAs) [undefined] on an ongoing basis for many private test kits and laboratories.

Thank you to Jessica Sousa and Louis Kang.